117 related articles for article (PubMed ID: 6194600)
1. Non-platinum-containing combination chemotherapy for stage III-IV head and neck squamous carcinoma.
Veronesi A; Magri MD; Tirelli U; Galligioni E; Frustaci S; Crivellari D; Tumolo S; Grigoletto E
Tumori; 1983 Aug; 69(4):323-6. PubMed ID: 6194600
[TBL] [Abstract][Full Text] [Related]
2. Intensive sequential chemotherapy with bleomycin, Oncovin, mitomycin C, and methotrexate followed by adriamycin, cisplatin, and cyclosphosphamide in squamous cell cancer of the head and neck.
Wheeler RH; Baker SR; Liepman MK; Ensminger WD
Med Pediatr Oncol; 1983; 11(1):12-9. PubMed ID: 6188032
[TBL] [Abstract][Full Text] [Related]
3. Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group.
Clavel M; Vermorken JB; Cognetti F; Cappelaere P; de Mulder PH; Schornagel JH; Tueni EA; Verweij J; Wildiers J; Clerico M
Ann Oncol; 1994 Jul; 5(6):521-6. PubMed ID: 7522527
[TBL] [Abstract][Full Text] [Related]
4. A phase II trial of cyclophosphamide and adriamycin in refractory squamous cell carcinoma of the head and neck. An effective salvage regimen.
Bitran JD; Goldman M
Am J Clin Oncol; 1985 Feb; 8(1):61-4. PubMed ID: 2581437
[TBL] [Abstract][Full Text] [Related]
5. Induction chemotherapy with cisplatinum, 5-fluorouracil, bleomycin, mitomycin C and hydroxyurea for previously untreated locally advanced squamous cell carcinomas of the head and neck.
Fountzilas G; Nicolaou A; Sridhar K; Sideras T; Haritanti A; Anastasakis C; Delis V; Vritsios A; Daniilidis J
Arch Otorhinolaryngol; 1989; 246(5):373-7. PubMed ID: 2480104
[TBL] [Abstract][Full Text] [Related]
6. Therapy of recurrent squamous cell carcinoma of the head and neck using combination vincristine, bleomycin, and methotrexate. A Southwest Oncology Group Study.
Smith RE; Heilbrun LK; Bottomley RM; Gad-el-Mawla N; Fletcher W
Cancer; 1986 Dec; 58(11):2382-5. PubMed ID: 2429754
[TBL] [Abstract][Full Text] [Related]
7. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
Amrein PC; Fabian RL
Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
[TBL] [Abstract][Full Text] [Related]
8. Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial.
Tobias JS; Monson K; Gupta N; Macdougall H; Glaholm J; Hutchison I; Kadalayil L; Hackshaw A;
Lancet Oncol; 2010 Jan; 11(1):66-74. PubMed ID: 19875337
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Gebbia V; Valenza R; Testa A; Borsellino N; Cannata G; Restivo S; Speciale R; Ingria F; Spadafora G; Gebbia N
ORL J Otorhinolaryngol Relat Spec; 1994; 56(5):279-82. PubMed ID: 7526312
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck.
Recloux P; Dodion PF; Andry G; Chantrain G; Dor P; Buyse M; Van Houtte P; Lemort M; Haesendonck P; Larsimont D
Eur J Surg Oncol; 1989 Dec; 15(6):568-74. PubMed ID: 2480922
[TBL] [Abstract][Full Text] [Related]
11. Alternating combination chemotherapy using cisplatin-bleomycin with sequential methotrexate-5-FU plus leucovorin rescue in patients with head and neck cancer.
Panasci L; Gravenor D; Black M; Frenkiel S; Margolese R
Cancer Treat Rep; 1985 Sep; 69(9):1015-7. PubMed ID: 2411401
[TBL] [Abstract][Full Text] [Related]
12. An original accelerated radiotherapy schedule in stage III to IV head and neck cancers. Results in a multicenter setting.
Allal AS; Monney M; Rosset A; Ozsahin M; Guillemin C
Strahlenther Onkol; 2000 Jan; 176(1):28-31. PubMed ID: 10650833
[TBL] [Abstract][Full Text] [Related]
13. Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma.
Lele SB; Piver MS
Gynecol Oncol; 1989 Apr; 33(1):6-8. PubMed ID: 2467845
[TBL] [Abstract][Full Text] [Related]
14. CDDP and 5-FU after prior VBM or VBM after prior CDDP and 5-FU in the management of recurrent squamous cell carcinoma of the head and neck?
Grimaldi A; Merlano M; Gardin G; Rosso R
Eur J Cancer Clin Oncol; 1986 Dec; 22(12):1539-40. PubMed ID: 2439343
[No Abstract] [Full Text] [Related]
15. Induction chemotherapy with a new regimen alternating cisplatin, fluorouracil with mitomycin, hydroxyurea and bleomycin in carcinomas of nasopharynx or other sites of the head and neck region.
Fountzilas G; Daniilidis J; Sridhar KS; Kalogera-Fountzila A; Zaramboukas T; Sombolos K; Destouni-Salem E; Vritsios A; Tourkantonis A
Cancer; 1990 Oct; 66(7):1453-60. PubMed ID: 1698526
[TBL] [Abstract][Full Text] [Related]
16. Mitomycin C, cisplatin, and 5-fluorouracil for advanced and/or recurrent head and neck squamous cell carcinomas.
Iop A; Cartei G; Vigevani E; Clocchiatti L; Mansutti M; Sibau AM
Am J Clin Oncol; 1997 Oct; 20(5):515-8. PubMed ID: 9345340
[TBL] [Abstract][Full Text] [Related]
17. Mitomycin-C, methotrexate, bleomycin and cis-diamminedichloroplatinum II in the chemotherapy of advanced squamous cancer of the head and neck.
Vogl SE; Lerner H; Kaplan BH; Camacho F; Cinberg J; Schoenfeld D
Cancer; 1982 Jul; 50(1):6-9. PubMed ID: 6177393
[TBL] [Abstract][Full Text] [Related]
18. Treatment of squamous-cell carcinoma of the head and neck with cisplatin and 5-fluorouracil.
Amrein PC; Weitzman SA
J Clin Oncol; 1985 Dec; 3(12):1632-9. PubMed ID: 2415693
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy of a patient with FIGO stage IV vulvar cancer with bleomycin, vincristine, mitomycin C, and cisplatin].
Shimizu Y; Hasumi K; Yagi H; Nakayama K; Chen JT; Hirai Y; Hamada T; Fujimoto I; Yamauchi K; Masubuchi K
Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):609-12. PubMed ID: 2474044
[No Abstract] [Full Text] [Related]
20. Failure of effective initial chemotherapy to modify the course of stage IV (MO) squamous cancer of the head and neck.
Vogl SE; Lerner H; Kaplan BH; Coughlin C; McCormick B; Camacho F; Cinberg J
Cancer; 1982 Sep; 50(5):840-4. PubMed ID: 6178496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
